Advertisement EY mid banner
RealVNC mid-banner general
Barr Ellison Solicitors – commercial property
Advertisement: RSM
Advertisement: Bradfield Centre mid
ARM Innovation Hub
Advertisement: Mogrify mid banner
Mid banner advertisement: BDO
Advertisement Cambridge China Centre
Advertisement: Cambridge Network
RealVNC mid banner careers
7 January, 2019 - 09:29 By Tony Quested

Global investors hand £1.1m lift-off for Cambridge EdTech innovator

CamBioScience Ltd, an innovator in advanced training and machine learning systems, has clinched around £1.1 million of funding from global backers, led by an early stage investment house, Beaubridge (UK) Ltd. 

The money will fuel the global scale-up of OBRIZUM®, a transformative learning platform that incorporates artificial intelligence (AI) to maximise and quicken individual employee learning and training processes—ultimately enhancing their company’s operations and development.

In leading the round, Beaubridge (UK joins an investor base that includes Cambridge Capital Group, Angels in MedCity, Henley’s Business Angels and private investors from the UK, Dubai, and Germany.

OBRIZUM® leverages powerful AI algorithms to continually personalise and enhance each employee’s learning experience. It also automates data organisation and transfer and generates deep, real-time analytical reports that quantify a company’s return on learning investment for businesses.

Businesses face an unrelenting challenge when it comes to employee empowerment via learning and training. They must evolve and maximise their processes or face extinction.

Dr Chibeza C. Agley, CEO and co-founder of CamBioScience, said: “OBRIZUM transforms E-Learning into AI-Learning and takes personalised learning to another level. 

“This latest financing from Beaubridge will help us realise OBRIZUM’s full global potential and bring powerful learning and training benefits to business and individuals alike—just when they need it most.”

CamBioScience’s leading AI specialists have built OBRIZUM® to make this transformation a reality by specifically addressing the three greatest challenges confronting digital learning – automation, personalisation and analytics.

“Businesses and individuals need to evolve from traditional static training processes to life- long learning. It is not an option but a requirement”, said Derk Ohler, Investment Director at Beaubridge (UK) Ltd. “We are investing in OBRIZUM because it is helping professionals and businesses meet this necessity.”

CamBioScience brings together cutting-edge technologists, leading academics, software developers and business visionaries to make deep data more user friendly; offer advanced life science training courses; and develop AI learning platforms that help transform the way people and businesses operate. 

• PHOTOGRAPH SHOWS: Dr Chibeza C. Agley

Newsletter Subscription

Stay informed of the latest news and features